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Evolution of minimal DNA tumor virus’ genomes has
selected for small viral oncoproteins that hijack crit-
ical cellular protein interaction networks. The struc-
tural basis for the multiple and dominant functions
of adenovirus oncoproteins has remained elusive.
E4-ORF3 forms a nuclear polymer and simulta-
neously inactivates p53, PML, TRIM24, and MRE11/
RAD50/NBS1 (MRN) tumor suppressors. We identify
oligomerization mutants and solve the crystal struc-
ture of E4-ORF3. E4-ORF3 forms a dimer with a
central b core, and its structure is unrelated to known
polymers or oncogenes. E4-ORF3 dimer units coas-
semble through reciprocal and nonreciprocal ex-
changes of their C-terminal tails. This results in linear
and branched oligomer chains that further assemble
in variable arrangements to form a polymer network
that partitions the nuclear volume. E4-ORF3 as-
sembly creates avidity-driven interactions with PML
and an emergent MRN binding interface. This reveals
an elegant structural solution whereby a small pro-
tein forms a multivalent matrix that traps disparate
tumor suppressors.
INTRODUCTION
Viral proteins offer a rich underexplored structural landscape in
which to discover optimized designs that target critical cellular304 Cell 151, 304–319, October 12, 2012 ª2012 Elsevier Inc.pathways. The higher replication and mutation rate of viruses
enables rapid protein evolution and exhaustive optimization.
Viral proteins can also explore physical forms forbidden to
cellular proteins because they do not have to be compatible
with the continued existence of the host; they just have to win.
Adenovirus is a small DNA tumor virus (<40 kb) that expresses
11 ‘‘early’’ E1 and E4 proteins that take over human cells, forcing
cells to propagate the viral genome and proteins (Berk, 2007).
Adenoviral early proteins achieve this by usurping the interac-
tions of multiple cellular targets that regulate growth and survival
(Weitzman and Ornelles, 2005). Elucidating the interactions
of adenoviral early proteins has been a powerful biochemical
strategy with which to discover key cellular targets and mecha-
nisms that are also deregulated in cancer, such as the RB/p107/
p130 family of tumor suppressors, E2F and p300 (O’Shea, 2005).
Adenoviral oncoproteins’ functions are all the more impressive
when realizing that the majority of them are less than 20 kDa
(the average human protein size is 53 kDa) and have little detect-
able sequence similarity to human proteins. This suggests that
they have found novel or optimized solutions to interact with
many different cellular protein hubs. However, no full-length
adenoviral oncoprotein structures have been solved (Ou et al.,
2011). Thus, the structural basis for their functions remains
unknown. This represents a fundamental gap in our understand-
ing of adenovirus, a global human pathogen and one of the pre-
dominant viral vectors used in both basic research and gene
therapy.
Elucidating the structure of adenoviral early proteins also has
a much broader impact. The rational design of small molecules
and proteins that disrupt the interactions of large cellular
protein-protein interaction complexes is amajor challenge (Wells
and McClendon, 2007). Cellular multifunctional protein interac-
tion hubs (Vidal et al., 2011) generally have large molecular
weights (>70 kDa) (Patil et al., 2010) that accommodate multiple
modular domains (Scott and Pawson, 2009) and/or local intrinsic
disordered regions to interact with many different binding part-
ners (Haynes et al., 2006). Based on this, it would be easy to
conclude that it is neither conceptually nor practically possible
to design small proteins that disrupt multiple large protein
complexes. The structures and functions of adenoviral oncopro-
teins could reveal new strategies for designing small proteins
that disrupt multiple large protein complexes.
Adenovirus E4-ORF3 is a small 116 residue (13 kDa) protein
that challenges our current understanding of the requisite prop-
erties of polymers and multifunctional protein-protein interaction
hubs. E4-ORF3 binds and inactivates multiple disparate tumor
suppressors and forms a remarkable network of cables that
weaves through the nucleus (Carvalho et al., 1995; Doucas
et al., 1996; Soria et al., 2010; Yondola and Hearing, 2007). In
contrast to actin and microtubules, which form uniform linear
filaments (Chhabra and Higgs, 2007; Howard and Hyman,
2003), E4-ORF3 forms highly irregular cable-like assemblies
(Carvalho et al., 1995; Doucas et al., 1996; Soria et al., 2010).
This suggests that E4-ORF3 is structurally distinct from cellular
polymers. However, the ultrastructure of E4-ORF3 assemblies
remains unknown.
The pleiotropic biological functions of E4-ORF3 include sup-
pression of the interferon response (Ullman et al., 2007), stimula-
tion of viral RNA splicing (Nordqvist et al., 1994), and prevention
of viral genome concatenation (Stracker et al., 2005). E4-ORF3
binds and disrupts large cellular protein complexes, including
PML bodies (Doucas et al., 1996), the MRE11/RAD50/NBS1
(MRN) DNA repair complex (Stracker et al., 2002), and TRIM24
(Yondola and Hearing, 2007). PML, MRN complex components,
and TRIM24 are important tumor suppressors that are inacti-
vated by mutations in several different cancers (Bernardi and
Pandolfi, 2007; D’Amours and Jackson, 2002; Khetchoumian
et al., 2007). Recently, E4-ORF3 was discovered to inactivate
p53 tumor suppressor functions by specifying repressive hetero-
chromatin assembly at p53 target promoters, thereby preventing
p53-DNA binding (Soria et al., 2010). The structural basis for
E4-ORF3’smultiple functions and inactivation of disparate tumor
suppressors is not understood.
Here,we show that E4-ORF3self-assembles to formapolymer
network in both plants and human cells. We identify dominant-
negative oligomerization mutants to solve the structure of an
E4-ORF3 dimer at 2.1 A˚ resolution. E4-ORF3 structure is not
related to that of known cellular oncogenes or polymer-forming
proteins but has a similar b core dimeric motif to that of the DNA
binding domain (DBD) of human papillomavirus 16 (HPV16) E2.
Based on structural, mutagenesis, and functional analyses, we
provide a model for E4-ORF3 assembly, namely that E4-ORF3
dimer units can coassemble through reciprocal and nonrecip-
rocal exchanges of their C-terminal tails. Using a genetically en-
coded tag for electron microscopy (EM), we show that E4-ORF3
polymers are disordered weaves of linear and branched olig-
omer threads that form a 3D network that partitions the nucleus
around viral replication domains. E4-ORF3 assembly is a unifying
mechanism required for inactivating PML,MRN, and p53 to facil-itate viral replication. We demonstrate that E4-ORF3 higher-
order assembly creates avidity-driven interactions with PML
and an emergent MRN binding interface at residues V101–D105
in the C-terminal tail. Together, our studies reveal a small-
ordered protein structure and assembly mechanism that binds
and disrupts multiple large tumor suppressor complexes.
RESULTS
E4-ORF3 Self-Assembles to Form an Irregular Polymer
Network in Both Human and Plant Cells
E4-ORF3 forms unusual ‘‘track’’-like superstructures in the
nucleus (Carvalho et al., 1995; Doucas et al., 1996; Soria et al.,
2010). Due to the limited resolution of light microscopy, it is
unclear if E4-ORF3 tracks are assemblies of multiple individual
fibers or a continuous polymer network. To investigate this
further, we applied super-resolution-structured illumination
microscopy (SR-SIM) (Gustafsson, 2000). E4-ORF3 forms highly
irregular looping cable-like assemblies adjacent to dense cellular
DNA superstructures that appear to be a single continuous poly-
mer structure at resolutions of approximately 100 nm (Figure 1A).
An important question is if E4-ORF3 requires accessory
human factors, such as an underlying nuclear architecture, cel-
lular interacting proteins, or DNA to assemble. There are no plant
homologs of the known E4-ORF3-interacting proteins. There-
fore, we expressed E4-ORF3 as a GFP fusion protein in Nico-
tiana benthamiana (tobacco). E4-ORF3-GFP is of a sufficiently
large size to be excluded from the nucleus but assembles into
a network of cables in the cytoplasm of Nicotiana cells that is
macroscopically similar to the structure it forms in the nucleus
of human cells (Figure 1B). We conclude that E4-ORF3 requires
neither nuclear localization nor accessory human factors to self-
assemble. Furthermore, these data demonstrate that E4-ORF3
is able to assemble even when it is fused to a protein that is
three times its size.
A Dominant-Negative Oligomerization Mutant that
Prevents E4-ORF3 Higher-Order Assembly and Is
Amenable to Structural Determination
The ability of E4-ORF3 to assemble in plants indicates that all the
necessary instructions for forming higher-order superstructures
are encoded within individual E4-ORF3 molecules. Therefore,
the atomic structure of E4-ORF3 is key to understanding both
its assembly and functions. Self-assembling polymeric proteins
present a notorious obstacle for structural analyses. E4-ORF3
is not an exception, and the wild-type (WT) protein forms insol-
uble aggregates when expressed in E. coli (data not shown).
Therefore, to solve the structure of E4-ORF3, we had to first
find a mechanism to isolate soluble oligomeric units and prevent
their polymerization.
As an initial step, we established an immunofluorescence
assay in human cells to monitor the coassembly of WT E4-
ORF3. When coexpressed together in U2OS cells, myc and
flag epitope-tagged E4-ORF3 proteins coassemble into a supra-
molecular scaffold (Figure 1C). This provided a cell-based assay
to identify mutations that prevent E4-ORF3 assembly. Previous
alanine-scanning mutagenesis of E4-ORF3 showed that substi-
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Figure 1. E4-ORF3 Self-Assembly Is Prevented by N82 Dominant-Negative Oligomerization Mutations
(A) SR-SIM image of Ad5-infected primary SAECs at 36 hr postinfection (hpi). E4-ORF3 is in green, DNA in blue.
(B) GFP (left) and E4-ORF3-GFP (right) inNicotiana benthamiana leaf epidermal cells. The cell wall (outlined with a dashed white line) is stained in blue, and plastid
autofluorescence is red.
(C) U2OS cells transfected with either myc-tagged E4-ORF3 (red), flag-tagged E4-ORF3 (green) or both together. DNA is counterstained with Hoechst (blue).
(D) Sequence alignment of E4-ORF3 from distal human adenoviral serotypes. The black box marks the conserved N82 residue.
(E) U2OS cells transfected with either myc-tagged E4-ORF3 N82A (red), flag-tagged E4-ORF3 (green) or an equal amount of both.
Scale bars, 5 and 1 mm (A) and 10 mm (B, C, and E). See also Figure S1.nuclear and cytoplasmic staining (Evans and Hearing, 2003;
Hoppe et al., 2006; Stracker et al., 2002). A trivial explanation
for this phenotype is that N82A mutations result in protein
misfolding. However, an alternative explanation is that N82A
mutations disrupt oligomeric interactions necessary for E4-
ORF3 assembly. We reasoned that if E4-ORF3 N82A is folded
it might act as a dominant-negative oligomerization mutant
and disrupt the assembly of WT E4-ORF3. Consistent with this,
when coexpressed together, myc-tagged E4-ORF3 N82A is
dominant and prevents the assembly of flag-tagged WT E4-
ORF3 (Figure 1E).
The identification of the dominant-negative oligomerization
properties of N82A mutants provided a mechanism for isolating
E4-ORF3 oligomeric units for structure determination. Unlike WT
E4-ORF3, the expression of E4-ORF3 N82A in E-coli yields306 Cell 151, 304–319, October 12, 2012 ª2012 Elsevier Inc.soluble protein that has a molecular weight consistent with a
dimer (see Figure S1A available online). Further protein engi-
neering was required to produce crystals that yielded high-reso-
lution diffraction data: C71 and C86 were each changed to serine
to prevent nonspecific disulfide crosslinking, and N82 was sub-
stituted with glutamic acid to enhance protein solubility. The
E4-ORF3 N82E/C71S/C86S triple mutant (abbreviated as E4-
ORF3N82*) eluted as a homogeneous protein dimer (Figure S1B)
and had the same dominant-negative properties as an N82A
singlemutantwhen coexpressedwithWTE4-ORF3 (Figure S1C).
In contrast, C71S/C86S double mutant does not prevent E4-
ORF3 assembly (Figure S1D). We obtained high-quality crystals
of seleno-methionine-labeled E4-ORF3 N82* and determined
the structure at 2.1 A˚ resolution using single-wavelength anom-
alous dispersion phasing (Table S1).
Crystal Structure of an E4-ORF3 Dimer
E4-ORF3 forms a dimer comprising three helices (a1, a2, and a3)
that pack against three antiparallel b strands (b1, b2, and b3) fol-
lowed by a ‘‘C-terminal tail’’ (amino acid residues 99–116) con-
taining a short b4 strand (Figures 2A and 2B). The b1–b3 strands
form the dimer interface, centered around a cluster of hydro-
phobic residues I2, C4, F50, Y62, and H64, with polar residues
R6, E52, and S60 at the bottom (Figure 2C). The dimeric b core
is sealed at the front and back via L111 in the b4 strand (Figures
2A and 2B). This is achieved by the bending back of the
C-terminal tail at a hinge region that comprises the highly con-
served 96TGGER100 residues (Figures 2A and 2B). The surface
area of the b core dimerization interface (1,504 A˚2) is close to
that observed in obligate dimers (1,712 A˚2) (Ponstingl et al.,
2000) and comprises 25% of the total surface area of each E4-
ORF3 dimer subunit. This suggests that E4-ORF3 is an obligate
dimer and that dimerization is the first-order event for higher-
order assembly.
E4-ORF3 specifies repressive heterochromatin assembly at
p53 target genes (Soria et al., 2010), suggesting that it may be
a direct DNA binding protein. However, DNA binding proteins
generally have a neutral or basic pI and electropositive clusters
on their surface (Brendel and Karlin, 1989). In contrast, E4-
ORF3 has an acidic pI (5.1), and the dimer has an electronegative
surface potential (Figure 2D). This suggests that E4-ORF3 acts
through intermediaries to silence p53 target genes or that the
assembly of E4-ORF3 dimer units creates an emergent DNA
binding surface.
E4-ORF3 Structural Homologs
Structural comparisons using Dali (Holm and Rosenstro¨m, 2010)
and PDBeFOLD (Krissinel and Henrick, 2004) servers show that
the structure of E4-ORF3 is distinct from that of known cellular
polymers or proteins that function in the p53, PML, DNA
damage, and TRIM24 tumor suppressor pathways. E4-ORF3
resembles proteins that have a ferredoxin-like fold. The top hit
in the Dali search was the Helicobacter pylori ISHp608 TnpA
DNA transposase (Ronning et al., 2005). However, TnpA and
E4-ORF3 have very different dimerization mechanisms, se-
quences, surface charges, and functions (Figures S2A–S2C).
TnpA has been suggested to have a similar topology to the
RNA recognition motif (RRM) (Ronning et al., 2005). E4-ORF3
also resembles the RRM topology (b1a1b2b3a2b4) but has an
additional a2 helix (Figure S2D). Furthermore, in E4-ORF3 the
b sheet is used for dimerization as opposed to nucleic acid
binding.
Strikingly, PDBeFOLD searches revealed that the DBD of the
HPV16 E2 protein (Hegde and Androphy, 1998) is a structural
homolog of E4-ORF3. E2 is a master viral transcription factor
that has a modular structure, comprising an N-terminal transac-
tivation domain linked to the C-terminal DBD (Giri and Yaniv,
1988). The superimposed structures of E4-ORF3 and E2 DBD
have a root-mean-square deviation (rmsd) of 2.9 A˚ with 72
structurally equivalent residue pairs (Figure 2E). However, only
9% of their amino acids are identical (Figure 2F). The E2 DBD
dimer has an electropositive surface (Figure 2G) and binds to
DNA via residues in the two a1 helices and the loop between
b2 and b3 (Hegde and Androphy, 1998; Kim et al., 2000). TheDNA binding residues and a1 helices are located on the same
face of the dimer to bind palindromic sequences in the HPV
genome (Figure 2G). Only three out of the eight E2 DBD a1
DNA binding residues are conserved in the corresponding a2
helix of E4-ORF3 (Figure 2F). Furthermore, the a2 helices are
on opposite faces of the E4-ORF3 dimer (Figure 2A).
Although their functions with respect to DNA binding may
differ, it is conspicuous that both E4-ORF3 and HPV16 E2 DBD
dimerize through a central b core (Figures 2A and 2G). Further-
more, the b core dimeric motif is also common to another DNA
tumor virus protein, the Epstein-Barr virus EBNA1 DBD (Fig-
ure 2G) (Bochkarev et al., 1995). However, neither E2 DBD nor
EBNA1 DBD dimers assemble to form a supramolecular struc-
ture similar to E4-ORF3.
E4-ORF3 Dimer Units Assemble through Intermolecular
Exchange of Their C-Terminal Tails
The dominant-negative oligomerization properties of E4-ORF3
N82* provide a functional assay to determine the structural basis
of WT E4-ORF3 assembly. N82 is in the middle of a3 and solvent
exposed (Figure 2A), suggesting that it is at a critical a3 interface
that is required for the assembly and stacking of E4-ORF3 poly-
mers. To test this, we mutated a3 residues that are on the same
helical ‘‘face’’ as N82 or similarly conserved (Figures 3A and S3A).
In contrast to N82A (Figure 1E), alanine substitutions of adjacent
and conserved residues in a3 do not prevent E4-ORF3 higher-
order assembly (Figures S3B and S3C). However, C86Amutants
exhibit some diffuse background staining compared to WT E4-
ORF3, suggesting that C86 may have a secondary role in stabi-
lizing E4-ORF3 assemblies (Figure S3B). These data do not
provide evidence for an extended a3 oligomeric interface having
a direct or critical role in E4-ORF3 assembly. This led us to deter-
mine if N82 mutations indirectly perturb distal oligomeric interac-
tions that are necessary for higher-order assembly.
Structural studies of oligomeric proteins have revealed three
mechanisms underlying the specific self-association of proteins
to form filaments, fibrils, or aggregates: end-to-end stacking
(actin and tubulin) (Chhabra and Higgs, 2007; Howard and Hy-
man, 2003); cross b-spine (amyloid and amyloid-like proteins)
(Sipe and Cohen, 2000); and 3D domain swapping (for example,
RNase A) (Bennett et al., 2006). End-to-end stacking and cross-
b-spine assembly mechanisms result in linear fibrils and aggre-
gates, respectively. However, E4-ORF3 assemblies are irregular
with variable curvatures and loops (Figure 1A). Furthermore, the
ability of E4-ORF3 to assemble when it is fused to GFP is not
consistent with end-to-end stacking and indicative of a flexible
assembly with relaxed packing constraints (Figure 1B).
In 3D domain swapping, the intermolecular exchange of
protein domains between oligomeric units can result in branched
irregular aggregates (Bennett et al., 2006). We hypothesized
that WT E4-ORF3 dimers coassemble through intermolecular
swapping of their C-terminal tails (Figure 3B). Our model sug-
gested that the N82 mutation causes a tertiary conformational
change that locks the C-terminal tail into a ‘‘closed’’ interaction
with the b core that prevents intermolecular exchanges (Fig-
ure 3B). An E4-ORF3 N82*-WT heterodimer would have a closed
dominant-negative configuration (Figure 3C) in which L111 seals







Figure 2. The Crystal Structure of an E4-ORF3 Dimer and Structural Homology to HPV16 E2 DBD
(A) The crystal structure of an E4-ORF3 N82E/C71S/C86S dimer at 2.1 A˚ resolution.
(B) E4-ORF3 secondary structure elements with corresponding amino acid sequences: b strands are indicated by arrows, a helices by cylinders, b core residues
are in orange, C-terminal tail residues are underlined, and hinge residues are indicated by a rectangle.
(C) b Core dimer interface.
(D) Surface electrostatic potential of E4-ORF3 dimer. Red represents a negative charge and blue a positive charge.







Figure 3. E4-ORF3 Dimers Assemble into a Higher-Order Polymer by Exchanging Their C-Terminal Tails
(A) Space-filling representation of E4-ORF3 N82* dimer structure in which L111 (cyan) seals the b core. a3 residues that were mutated to alanine are shown in the
model and indicated by an asterisk in the sequence below. Blue dots indicate residues on the same helical face as N82. Conserved residues are labeled red.
(B) Left panel is a top-down representation of the E4-ORF3 N82* dimer structure shown in (A), in which the C-terminal tail is locked into a closed configurationwith
the b core. The b core is represented by a sphere with a stripe at the dimer interface, the mutated N82 residue is indicated by an asterisk (*), and L111 is depicted
as a circle. The right panel is a model for how wild-type E4-ORF3 dimers could further assemble through intermolecular exchanges of their C-terminal tails.
(C–G) U2OS cells transfected with either myc-tagged E4-ORF3 mutants (red), flag-tagged E4-ORF3 (green) or equal amounts of both. Models of mutant and WT
E4-ORF3 interactions are shown.
Scale bars, 10 mm. See also Figure S3.To test our hypothesis and open the b core for intermolecular
interactions, we deleted the C-terminal tail (residues 99–116,DC)
in E4-ORF3 N82A. E4-ORF3 N82ADC is diffuse; analogous to
N82A alone (Figures 3C and 3D). However, in contrast to N82A
single mutation, E4-ORF3 N82ADC is no longer a dominant-
negative oligomerization mutant that prevents the assembly of
WT E4-ORF3. Instead, E4-ORF3 N82ADC coassembles with
WT E4-ORF3 (Figure 3D). In the crystal structure of E4-ORF3
N82*, L111 in the C-terminal tail seals the b core (Figure 3A).(E) HPV16 E2 DBD is a structural homolog of E4-ORF3 with an rmsd of 2.9 A˚.
(F) Alignment of HPV16 E2 DBD and E4-ORF3 sequences based on their structur
HPV18 E2 DBD a1 helix are highlighted with a cyan box.
(G) Both HPV16 E2 DBD and EBNA-1 DBD form dimers with a central b barrel an
paper (oval).
See also Figure S2 and Table S1.Similar to N82ADC, E4-ORF3 N82A/L111K is not a dominant
negative, and its assembly is rescued in trans by the coexpres-
sion of WT E4-ORF3 (Figure 3E). These data are consistent
with our model and demonstrate that N82A mutants are able
to coassemble with WT E4-ORF3 when the b core is made avail-
able for intermolecular interactions by additional mutations
(Figures 3D and 3E).
We next determined if the C-terminal tail is required for WT E4-
ORF3 assembly. E4-ORF3 DC is diffuse, demonstrating that theal overlap; identical residues are colored red. Residues that contact DNA in the
d have electropositive surfaces. Dimer axes are perpendicular to the plane of
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C-terminal tail is required for E4-ORF3 assembly (Figure 3F). One
explanation for this phenotype is that the deletion of the
C-terminal tail results in a destabilized E4-ORF3 dimer or proto-
mer. However, E4-ORF3 DC assembly is rescued by the coex-
pression of full-length E4-ORF3 (Figure 3F). These data argue
that E4-ORF3 DC at least forms heterodimers with the WT pro-
tein. Furthermore, these data indicate that E4-ORF3 dimers can
coassemble through nonreciprocal C-terminal tail exchanges.
In contrast to the deletion of the C-terminal tail, an L111K
mutation does not prevent E4-ORF3 assembly (Figure 3G).
Thus, L111K mutations selectively disrupt the interactions of
the C-terminal tail with the b core in E4-ORF3 N82* mutants,
but not WT E4-ORF3 (Figures 3E and 3G). We conclude that
the C-terminal tail is critical for E4-ORF3 higher-order assembly
and that N82 mutations alter L111 interactions with the b core.
WT E4-ORF3 Dimers Have an Extended b4 Strand that
Completes the b Barrel to Drive Higher-Order
Oligomerization
This failure of L111K to prevent E4-ORF3 assembly is surprising
and leads to a major question: What are the molecular interac-
tions between the C-terminal tail and the b core in WT E4-
ORF3 that are critical for higher-order assembly? The similar
dimerization modes of E4-ORF3 and E2 DBD provided a vital
clue. In the E2 DBD dimer, the b4 strand interacts with both b1
and b40 (Figure 4A), forming a b barrel. In the E4-ORF3 N82*
dimer, the b4 strand is short (three residues) and interacts with
b1, but not b20. Based on the E2 DBD dimer structure, we
hypothesized that in WT E4-ORF3 the b4 strand is extended,
completing the b barrel (Figure 4A). To test this, we made lysine
substitutions at individual residues from D112 to E116 to abolish
potential interactions with the hydrophobic b core. D112K,
L114K, and E116Kmutations do not prevent E4-ORF3 assembly
(Figure 4B). In contrast, L115K and N113K prevent E4-ORF3
assembly of a nuclear polymer network and result in diffuse
staining or a mixture of diffuse staining with cytoplasmic aggre-
gates, respectively. These results are consistent with residues
109–116 forming an extended b4 strand in WT E4-ORF3, in
which every other residue from L111 faces the hydrophobic
core (Figure 4C). This would change the position of L111 and
place it more near the base of the b core, which is polar (Fig-
ure 4C). This would potentially explain why a L111K mutation
does not prevent WT E4-ORF3 higher-order assembly (Fig-
ure 3G). Together, these data demonstrate that N82 mutations
alter the interactions of theC-terminal tail with the b core, thereby
preventing higher-order oligomerization.
In 3D domain swapping the exchanged domain is generally at
the N or C terminus and linked to the protein core by a flexible
‘‘hinge-loop’’ (Bennett et al., 2006). Therefore, we determined
if the glycine residues in the hinge region between a3 and
the C-terminal tail facilitate E4-ORF3 higher-order assembly
(Figures 2A and 2B). E4-ORF3 DG97/DG98 is diffuse but rescued
in trans by WT E4-ORF3 (Figure 4D). Thus, the hinge residues
G97G98 are also required for E4-ORF3 assembly.
Model of E4-ORF3 Polymerization
Taken together, we propose the following model: the first-order
step in E4-ORF3 assembly is dimerization via b sheet interac-310 Cell 151, 304–319, October 12, 2012 ª2012 Elsevier Inc.tions. Dimerization creates new interfaces for higher-order
assembly: the front and backside of the dimeric b core. The
two b4 strands in each E4-ORF3 dimer can interact with the
b cores of adjacent dimers, driving higher-order assembly (Fig-
ure 4E). Reciprocal exchanges of the C-terminal tails between
dimer units would result in more linear assemblies, whereas
nonreciprocal swapping would enable branching. The glycine
residues in the hinge of the C-terminal tail could also adopt
various backbone dihedral angles, enabling E4-ORF3 domain-
swapped dimers to have diverse and flexible orientations. This
would result in many different oligomer configurations that could
further assemble with each other through avidity-driven interac-
tions (Figure 4E). Our model predicts that E4-ORF3 polymerizes
in multiple ways to form a disordered protein superstructure
that has multivalent binding sites to interact with many different
cellular complexes.
EM Ultrastructure of E4-ORF3 Polymer Assemblies
E4-ORF3 assemblies are refractory to visualization using con-
ventional EM preparations (Carvalho et al., 1995; Morgan et al.,
1960; Puvion-Dutilleul et al., 1995), and immunogold labeling is
of limited value in elucidating the ultrastructure of polymers.
MiniSOG (singlet oxygen generator) is a fluorescent 106-residue
protein tag with which to visualize proteins by correlated light
and EM (Shu et al., 2011). Fluorescence photo-oxidation of min-
iSOG catalyzes the local formation of an electron-dense polymer
on the surface of the fusion protein that can be detected by EM.
Therefore, to visualize E4-ORF3 by EM, we created miniSOG-
E4-ORF3 fusion constructs. Our first attempts with N- and
C-terminal miniSOG fusions resulted in cytoplasmic aggregates
(Figure S4A). Based on the crystal structure of E4-ORF3, we
inserted miniSOG in the flexible loop region between a2 and
b2 at residue G46 (Figure 2B). E4-ORF3 constructs with an
internal miniSOG fusion assemble a functional nuclear scaffold
thatmislocalizes PML, analogous to untagged E4-ORF3 in trans-
fected U2OS cells (Figure S4A). To reveal the ultrastructure of
E4-ORF3 in the biologically relevant context of viral infection,
we engineered Ad5 viruses that express miniSOG-E4-ORF3 in
place of endogenous E4-ORF3 (Figure 5A). The miniSOG-E4-
ORF3 nuclear assemblies were photo-oxidized and visualized
by correlated light and EM (Figure 5B).
Transmission EM (TEM) images show that E4-ORF3 nuclear
assemblies are distinct from cellular polymers, cytoskeletal
structures (Aebi et al., 1986), and amyloid-like aggregates (Sipe
and Cohen, 2000). E4-ORF3 assemblies are irregular, make
U-turns at the nuclear membrane, and form loosely to densely
packed bundles (Figures 5C and 5D). A high-resolution tomo-
gram shows that E4-ORF3 polymer assemblies are a weave of
what appear to be thin oligomer threads that assemble with
one another in no consistent order (Figure 5E; Movie S1). Each
slice of the E4-ORF3 tomogramhas a distinct pattern. Consistent
with our model (Figure 4E), both linear and branched chain
configurations are observed, although the former are predomi-
nant. Furthermore, individual oligomer threads are not stacked
with one another throughout their lengthsbut appear to associate
at multiple points in no fixed geometric arrangement.
E4-ORF3 polymer assemblies do not project in a single plane.




Figure 4. Intermolecular Swapping of an Extended b4 Strand Completes the b Barrel in WT E4-ORF3 Dimers to Drive Higher-Order Oligo-
merization
(A) In the HPV16 E2DBD dimer, b4 interacts with both b1 and b40 to form a b barrel. In the E4-ORF3 N82* dimer, the short b4 strand does not complete the b barrel.
(B) U2OS cells transfected with E4-ORF3 b4 point mutants (red).
(C) In E4-ORF3 N82* a short b4 strand seals the b core through L111 interactions (left panel). A model showing that WT E4-ORF3 has an extended b4 strand in
which alternating residues face the b core (right panel).
(D) U2OS cells transfected with myc-tagged E4-ORF3 DG97/DG98 (red), flag-tagged E4-ORF3 (green), or both.
(E) Model showing E4-ORF3 polymer assembly through a combination of both reciprocal and nonreciprocal C-terminal tail exchanges between dimer units,
resulting in linear and branched oligomer chains.
Scale bars, 10 mm.
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Figure 5. EM Ultrastructure of E4-ORF3 Polymer Assemblies and Nuclear Matrix
(A) U2OS cells were infected with Ad5 viruses that express miniSOG-E4-ORF3, photooxidized, and imaged by TEM, tomography, and SBFSEM.
(B) MiniSOG-E4-ORF3 prior to photooxidation (left: transmitted light; middle: fluorescence) and postphotooxidation (right: transmitted light).
(C and D) TEM images of E4-ORF3 assemblies (black arrow). Nuclear membrane (double arrow). Scale bars, 500 nm (C) and 100 nm (D).
(E) Individual cross sections (each 5 A˚ thick) of an E4-ORF3 tomogram volume (from top) with inset panel zooms. Arrows indicate linear assemblies; arrowheads
indicate branched junctions. Scale bar, 200 nm.
(F) SBFSEM of E4-ORF3 in which 150 serial section images (each 60 nm thick) were reconstructed. Scale bar, 1 mm.
(G and H) Segmentation of SBFSEM data set. E4-ORF3 is in white, nucleoli in blue, viral replication domains are in red, and the nuclear membrane is in yellow.
Scale bar, 5 mm.
See also Figure S4 and Movies S1, S2, S3, and S4.
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E4-ORF3 polymer networks through the entire nuclear volume,
we used serial block-face scanning electron microscopy
(SBFSEM) (Denk and Horstmann, 2004). Images of 150 consec-
utive 60 nm sections were acquired from the bottom to the top
of infected cells (Figures 5F–5H and S4B; Movies S2, S3,
and S4). E4-ORF3 forms a network that circumnavigates the
nucleoli and creates physical partitions around viral DNA repli-
cation domains (Figures 5G and S4C; Movie S4). The E4-ORF3
polymer networks have distinct topologies in individual cells
(Movies S2 and S3), project in multiple dimensions, and have
variable diameters, ranging from 60 to 710 nm in different places
(Figure S4D). We conclude that E4-ORF3 assembles in multiple
ways to form a disordered protein superstructure and 3D poly-
mer network that physically partitions the nucleus.
E4-ORF3 Higher-Order Oligomerization Is Critical for
Inactivating Disparate Tumor Suppressors and
Facilitating Viral Replication
These data beg the question if E4-ORF3 assembly is required for
its biological functions and interactions in viral replication. In
adenovirus infection, E4-ORF3 and E1B-55K early viral oncopro-
teins have overlapping functions in inactivating p53 and MRN
(Soria et al., 2010; Stracker et al., 2002). Therefore, to determine
if E4-ORF3 higher-order assembly is necessary for p53 inactiva-
tion, we engineered adenoviruses that have an E1B-55K deletion
and an N82A mutation in E4-ORF3. As expected, in DE1B-
55K-infected primary cells, WT E4-ORF3 assembles a nuclear
scaffold and prevents p53-activated transcription of p21 and
MDM2 (Figures 6A and S5) (Soria et al., 2010). However, in
DE1B-55K/E4-ORF3 N82A-infected cells, E4-ORF3 is unable
to assemble a nuclear scaffold and inactivate p53 targets (Fig-
ures 6A and S5). Furthermore, E4-ORF3 N82A also fails to
disrupt PML bodies (Figure 6B) or mislocalize NBS1 (a key com-
ponent of the MRN complex) (Figure 6C). Consistent with this,
DE1B-55K/E4-ORF3 N82A viruses are profoundly defective
and do not form E2A viral DNA replication domains or express
viral capsid proteins (Figures 6D and 6E). These data strongly
suggest that the higher-order assembly of E4-ORF3 dimers is
a unifying mechanism that is required for E4-ORF3’s functions
in inactivating disparate tumor suppressors and driving patho-
logical viral replication.
E4-ORF3 Higher-Order Oligomerization Creates Avidity-
Driven Interactions with PML and an Emergent MRN
Binding Interface
We hypothesized that E4-ORF3 higher-order oligomerization is
required for creating emergent binding sites and/or avidity-driven
interactions with cellular partners (Figure 7A). The assembly of
E4-ORF3 into a polymer would substantially reduce the ‘‘off-
rate’’ of possible low-affinity interactions between individual
E4-ORF3dimer units and cellular partners by usingmultiple inter-
action points. Avidity-driven interactions require both partners
to have multivalent binding sites (Mammen et al., 1998). Strik-
ingly, PML is an oligomeric protein that forms nuclear ‘‘bodies’’
(Bernardi and Pandolfi, 2007), and the MRN complex assembles
into foci at DNA breaks (D’Amours and Jackson, 2002).
We reasoned that if polymerization is critical for avidity-driven
interactions, then E4-ORF3 N82A dimers that are engineered toassemble a higher-order superstructure through an independent
oligomerization mechanism would bind and mislocalize PML
and MRN (Figure 7B). Lamin A/C is a cellular protein that assem-
bles 32-mer to form the nuclear lamina, an intermediate filament
network (Herrmann et al., 2007). Therefore, to test our hypoth-
esis, we created a protein fusion between Lamin A/C and
E4-ORF3 N82A. Lamin A/C-E4-ORF3 N82A assembles into a
nuclear superstructure that is distinct from Lamin A/C, WT E4-
ORF3, and E4-ORF3 N82A (Figure 7C). Lamin A/C-E4-ORF3
N82A forms ring-like cylinders through the nucleus that disrupt
and mislocalize PML. Thus, E4-ORF3 N82A mutants are
perfectly capable of binding and mislocalizing PML when they
are assembled into a higher-order oligomer by Lamin A/C
fusions. We conclude that the higher-order assembly of E4-
ORF3 creates avidity-driven interactions that capture and dis-
rupt PML bodies.
In contrast to PML, Lamin A/C-E4-ORF3 N82A does not bind
and mislocalize NBS1 (Figure 7D). This suggested that the
higher-order assembly of E4-ORF3 dimers through C-terminal
tail swapping is specifically required for interactions with MRN.
Previously, I104 was implicated as a key residue that underlies
the differential ability of Ad5 E4-ORF3 to bind and mislocalize
MRN (Carson et al., 2009). In the E4-ORF3 N82* dimer structure,
I104 is solvent exposed in a random coil region between the hinge
residues and b4 in the C-terminal tail (Figure 7E). Thus, I104 is on
the surface and available for binding in E4-ORF3 N82* dimers.
However, this is not sufficient for MRN binding, even as part of
a Lamin A/C-E4-ORF3 N82A avidity surface (Figure 7D).
Therefore, we hypothesized that I104 is part of an emergent
MRN binding interface that is formed upon swapping of the
C-terminal tails between E4-ORF3 dimer units (Figure 7E). To
test this, we performed alanine-scanning mutagenesis of the
residues in the random coil of the C-terminal tail (Figures 7E
and S6A). V101A, H102A, I104A, and D105A mutations ablate
E4-ORF3 interactions with NBS1 (Figures 7E and S6A). Further-
more, L103A prevents not only NBS1 binding but also E4-ORF3
assembly (Figures 7E and S6A). This suggests that L103 is impor-
tant for secondary oligomeric interactions that favor and stabilize
the ‘‘swapped’’ state. Finally, we show that the fusion of the
C-terminal tail alone to Lamin A/C is not sufficient to mislocalize
NBS1 to the nuclear lamina (Figure S6B). Together, these data
suggest that C-terminal tail swaps create an emergent interface
at residues V101–D105 that is critical for MRN binding and E4-
ORF3 assembly.
DISCUSSION
Adenovirus early protein interactions have led to the discovery
of many of the critical cellular growth regulatory targets and
mechanisms. However, the structural basis for their multiple
functions and interactions has remained elusive due to the
paucity of high-resolution structural information. Here, we deter-
mine the crystal structure of E4-ORF3 at 2.1 A˚ resolution. E4-
ORF3 is not a structural homolog of any known cellular proteins
that form polymers or that function in the p53, DNA damage,
PML, or TRIM24 tumor suppressor pathways. However, E4-
ORF3 shares a similar dimeric motif with HPV16 E2 DBD and

































































































Figure 6. E4-ORF3 Higher-Order Oligomerization Is Critical for Inactivating Disparate Tumor Suppressors and Facilitating Viral Replication
(A) Primary SAECswere infectedwith eithermock, Ad5 (WT),DE4-ORF3,DE1B-55K,DE1B-55K/DE4-ORF3 orDE1B-55K/E4-ORF3N82A viruses. Protein lysates
were harvested at 36 hpi, normalized, and immunoblotted for p53, MDM2, and p21. b-Actin is a loading control.
(B–D) Confocal images of infected SAECs immunostained for E4-ORF3 (green) and (B) PML (red), (C) NBS1 (red), (D) E2A viral replication domains (red). Scale
bar, 10 mm.
(E) As per (A), except lysates were immunoblotted for Ad5 capsid proteins.
See also Figure S5.
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intriguing possibility that these disparate viral proteins evolved
from a common ancestor. Alternatively, they may have indepen-
dently converged on the same structural solution because it
represents an optimal combination in terms of minimizing proto-
mer size and maximizing functional versatility.
To determine the structure and assembly mechanism of E4-
ORF3, we exploited a dominant-negative oligomerizationmutant
(N82A). The crystal structure reveals the first-order subunit of E4-
ORF3 polymer assemblies and dimerization interface. The N82
mutation is in the a3 helix, suggesting that it is at a critical oligo-
meric interface. However, mutagenesis studies did not reveal
any additional residues in a3 that prevent E4-ORF3 assembly
(Figures 3A and S3). We demonstrate that C-terminal tail dele-
tions or L111K ablates the dominant-negative effects of N82A
mutants and enables coassembly with WT E4-ORF3 (Figures
3D and 3E). Thus, N82A mutations do not directly prevent the
assembly and stacking of WT E4-ORF3 when the b core is
made available for intermolecular interactions.
Our data suggest that N82 mutations result in tertiary confor-
mational changes that alter C-terminal tail interactions with the
b core, thereby preventing b4 exchanges that drive higher-order
assembly. This is consistent with our mutational analyses, which
indicate that in contrast to the N82* crystal structure, in WT E4-
ORF3 the b4 strand is extended and completes the dimer b barrel
(Figures 3E, 3G, 4B, and 4C). It is not clear why N82 mutations
would have such a drastic effect on C-terminal tail interactions
with the b core. One possibility is that N82 mutations inhibit
E4-ORF3 conformational heterogeneity thereby preventing in-
termolecular exchanges of the C-terminal tail. In such a model,
N82 interactions could act as a molecular switch that modulates
E4-ORF3 assembly. A precedent for this exists in other domain-
swapped proteins, where conformational heterogeneity has
been reported to facilitate exchanges, for example, the b4 strand
of CKS1 (Seeliger et al., 2005). In future studies, a cocrystal
structure of E4-ORF3 N82* with WT E4-ORF3 would help to
clarify the molecular interactions of N82 in E4-ORF3 assembly.
Together, our studies suggest a model in which E4-ORF3
dimers coassemble through a combination of both reciprocal
and nonreciprocal swapping of their C-terminal tails (Figure 4E).
Reciprocal exchanges would result in more linear assemblies
and nonreciprocal swapping in branched chains. Avidity interac-
tions between oligomer chains would further drive assembly
and result in variable arrangements and loose stacking require-
ments. This would rationalize the unusual ability of E4-ORF3 to
assemble even when it is fused to miniSOG or GFP (Figures 1B
and 5B), which is indicative of relaxed packing constraints.
The EM ultrastructure of E4-ORF3 polymer bundles is, for
the most part, consistent with our model (Figures 4E and 5E;
Movie S1). A tomogram reveals that E4-ORF3 assemblies are
a disordered weave of individual oligomer threads that associate
with one another in no fixed geometric arrangement. Although
branching is observed, the oligomer threads exhibit a pre-
dominantly linear configuration. This suggests that reciprocal
exchanges between E4-ORF3 dimer units are favored over
nonreciprocal swaps. In other 3D domain-swapped proteins,
reciprocal exchanges result in juxtaposed hinge residues that
interact with one another to stabilize the ‘‘swapped’’ state (Liu
et al., 2011). The random coil region adjacent to the hinge isa candidate for forming such a secondary oligomeric interface,
as evidenced by the effects of L103A mutations in preventing
E4-ORF3 assembly (Figure S6A). If a secondary L103 oligomeric
interface is formed between residues in adjacent C-terminal
tails, this would potentially favor reciprocal over nonreciprocal
exchanges. Based on the crystal structure, L103A mutants
would at least form dimers and be an interesting candidate for
structural determination. No doubt, future studies will test these
various models and the role of the random coil region and
C-terminal tail in driving E4-ORF3 assembly and binding with
cellular proteins.
The SBFSEM reconstructions show that E4-ORF3 forms
a network of cables that physically separate viral replication
domains from cellular nucleoli and chromatin (Figure 5G; Movie
S4). E4-ORF3 specifically silences p53 target genes (Soria
et al., 2010), but the E4-ORF3 nuclear network in each cell is
distinct (Movies S2 and S3). One possible explanation is that
E4-ORF3 assembly nucleates at specific points and then ex-
pands into the interchromatin space, which is more variable.
Concentrating E4-ORF3 at specific loci would also create a
crowded molecular environment that favors 3D domain swap-
ping (Liu and Eisenberg, 2002). Thus, the sites of E4-ORF3 nucle-
ation could unveil an underlying nuclear organization.
The E4-ORF3 nuclear polymer network is akin to a semisolid
interaction matrix that would not be expected to exhibit tradi-
tional diffusion kinetics. The interactions of such a polyvalent
matrix with its binding partners could exceed that of avidity
and affinity-driven interactions. Such ‘‘matricity’’-driven interac-
tions have previously been described for clathrin, in which
multiple weak binding sites form a dominant chelating surface
upon polymerization (Schmid et al., 2006). E4-ORF3 assembly
is required for its functions in inactivating p53, PML, MRN, and
driving viral replication (Figure 6). We show that the assembly
of E4-ORF3 creates avidity-driven interactions with PML and
an MRN binding interface between residues V101 and D105 in
the C-terminal tail (Figure 7). The emergent interactions of E4-
ORF3 polymers explain a central paradox, namely why cellular
binding partners do not prevent E4-ORF3 polymerization. The
answer is that E4-ORF3 interactions require assembly. We
conclude that E4-ORF3 binds to PML and MRN via two distinct
molecular mechanisms, which are emergent functions of its
higher-order oligomerization.
Our studies reveal an elegant structural solution whereby a
small-ordered protein forms a dominant protein interaction
matrix to capture and disrupt multiple large cellular protein
complexes (Figure 7F). In general, multifunctional cellular protein
hubs are large with multiple modular domains (Patil et al., 2010)
and/or intrinsically disordered regions (Dunker et al., 2005) that
enable them to bind many different partners simultaneously.
The archetypal adenovirus oncoprotein, E1A, is mostly unstruc-
tured and uses intrinsically disordered short peptide motifs to
bind multiple cellular partners (Ferreon et al., 2009; Pelka
et al., 2008). E4-ORF3 flouts these conventions and instead
uses a small domain to assemble a disordered protein super-
structure that has multiple different binding sites. Thus, E4-
ORF3 represents a new type of multifunctional hub and protein
polymer that redefines the possibilities and potential for such




Figure 7. E4-ORF3 Assembly Creates Avidity-Driven Interactions with PML and an Emergent MRN Binding Site
(A) Models showing E4-ORF3 assembly is required to create emergent binding sites and/or avidity-based interactions with PML and MRN tumor suppressor
complexes.
(B) To test this model, E4-ORF3 N82A was assembled by fusing it to an independent oligomeric protein, Lamin A/C (orange).
(C) U2OS cells transfected with either Lamin A/C-Flag, E4-ORF3, E4-ORF3 N82A or Lamin A/C-E4-ORF3 N82A fusions (green) and immunostained for PML (red)
or (D) NBS1 (red). The nucleus is traced with a white line. Images are a single confocal slice. Scale bars, 5 mm.
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Although E4-ORF3 is the first complete adenoviral early onco-
protein structure to be solved, we propose that viral early
proteins in general may offset their limited surface areas by
assembling different oligomeric complexes to usurp cellular pro-
tein interactions. The same principles revealed by E4-ORF3’s
structure-function are presaged by organic chemists’ design of
multivalent dendrimers to target cell surface ligands, where
multiple weak contacts in a flexible scaffold are more efficient
and selective than precise structures with stronger individual
interactions (Martos et al., 2008). Finally, the structure of E4-
ORF3 provides a rational basis for identifying new protein inter-
action surfaces that target critical tumor suppressors.
EXPERIMENTAL PROCEDURES
Cells, Plasmids, Transfections, and Viral Infections
Primary small airway epithelial cells (SAECs) were cultured and infected using
established conditions (Soria et al., 2010). Protein lysates from infected cells
were normalized and analyzed by western blotting. U2OS cells were trans-
fected using Lipofectamine 2000 (Invitrogen). A 1:1 mix of WT and mutant
E4-ORF3 plasmids was used. Refer to Extended Experimental Procedures
for additional details.
Immunofluorescence
Cells were fixed in 4%paraformaldehyde and stained using established condi-
tions (Soria et al., 2010). Imageswere acquired using a Zeiss LSM710 confocal
microscope and Zeiss Elyra S.1 super-resolution-structured illumination
microscope. Refer to Extended Experimental Procedures for additional details.
Expression of E4-ORF3 in Nicotiana benthamiana
mGFP5 and E4-ORF3-mGFP5 C-terminal fusion constructs were transformed
into the Agrobacterium strain ASE and used for infiltration of Nicotiana ben-
thamiana as previously described bySparkes et al. (2006). Leaf plugswere har-
vested at 54 hr and stained with SCRI Renaissance 2200. Images were ac-
quired using a 403 objective and aremaximum projections of 22 optical slices.
Bacterial Protein Expression and Purification
E4-ORF3 constructs were expressed in the Rosetta E. coli strain (Novagen).
63-his-tagged proteins were purified using QIAGEN Ni-NTA Superflow Se-
pharose and a Superdex 200 16/60 size exclusion column. Additional details
can be found in Extended Experimental Procedures.
Crystallization
Seleno-methionine-labeled E4-ORF3 N82E/C71S/C86S was concentrated to
14.6 mg/ml and crystallized by hanging drop in 0.1 M HEPES (pH 7.0), 15%
PEG 10,000, and 8% ethylene glycol with 1 ml protein solution and 1 ml precip-
itant solution. Crystals appear within 2 weeks. The crystals were flash frozen in
the same buffer with 20% PEG 10,000.
Data Collection and Structure Refinement
Diffraction data were collected for a SeMet crystal at Stanford Synchro-
tron Radiation Lightsource beamline 9-2 to 2.06 A˚. The crystal structure of
E4-ORF3 was solved by single-wavelength anomalous dispersion using the
selenium signal. Refinement of the structure was completed after multiple
cycles, and noncrystallographic symmetry restraints were not applied. Data
processing and refinement statistics are listed in Table S1. Final R and Rfree
values are 0.212 and 0.256, respectively. All figures were prepared with(E) The top panel shows residues V101–D105 in the C-terminal tail of the E4-ORF3
which indicates that they form an emergent MRN binding site and secondary oli
(F) E4-ORF3 forms dimers that further assemble in many different configuration
suppressor complexes and silences p53 target promoters in cellular chromatin.
See also Figure S6.PyMOL (Delano, 2002). Additional details are in Extended Experimental
Procedures.
Dali and PDBeFOLD Homology Search
The structural coordinates of E4-ORF3 N82* were used to search the Dali
(http://ekhidna.biocenter.helsinki.fi/dali_server/) and PDBeFOLD servers
(http://www.ebi.ac.uk/msd-srv/ssm). For PDBeFOLD, shared secondary
structural element between query and target proteins was set at 60%.
Correlated Light and EM
Cells were grown and infected on MatTek dishes and fixed with 2% glutaral-
dehyde. Regions of interest were selected using a Leica SPE-II microscope,
photo-oxidized, and stained as described previously (Shu et al., 2011). Ultra-
thin sections were cut and electron micrographs recorded using a 1200 TEM
(JEOL). For SBFSEM, a 3View system (Gatan) mounted in a Quanta FEG vari-
able pressure scanning electron microscope (FEI) with an oscillating diamond
knife was used to image blocks at 60 nm increments. Segmentation was per-
formed using IMOD (Kremer et al., 1996). Refer to Extended Experimental
Procedures for additional details.
Electron Tomography
Sections were cut at 250 nm thickness andmounted on 75mesh copper grids.
Images were recorded at 40,0003magnification and angular increments of 2
from 60 to +60 using a JEOL 4000EX intermediate voltage electron micro-
scope operated at 400kV. Images were aligned and reconstructed using
IMOD, TxBR, and Amira. The reconstructed tomogram comprises 500 compu-
tational slices (each 0.5 nm). Refer to Extended Experimental Procedures for
additional details.
ACCESSION NUMBERS
The Protein Data Bank accession number for the E4-ORF3 atomic coordinates
and structure factors reported in this paper is 4DJB.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, one table, and four movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2012.08.035.
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